A detailed history of Game Creek Capital, LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Game Creek Capital, LP holds 11,875 shares of MRK stock, worth $1.5 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
11,875
Previous 12,625 5.94%
Holding current value
$1.5 Million
Previous $1.38 Million 13.81%
% of portfolio
0.75%
Previous 0.59%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $84,930 - $98,962
-750 Reduced 5.94%
11,875 $1.57 Million
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $663,692 - $722,257
6,625 Added 110.42%
12,625 $1.38 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $64,343 - $71,456
-625 Reduced 9.43%
6,000 $617,000
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $122,186 - $133,177
-1,125 Reduced 14.52%
6,625 $764,000
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $321,687 - $358,937
-3,125 Reduced 28.74%
7,750 $824,000
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $87,440 - $112,110
-1,000 Reduced 8.42%
10,875 $1.21 Million
Q3 2022

Nov 04, 2022

SELL
$84.53 - $94.96 $496,613 - $557,890
-5,875 Reduced 33.1%
11,875 $1.02 Million
Q2 2022

Aug 09, 2022

SELL
$83.49 - $94.64 $688,792 - $780,780
-8,250 Reduced 31.73%
17,750 $1.62 Million
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $845,365 - $947,600
-11,500 Reduced 30.67%
26,000 $2.13 Million
Q4 2021

Feb 09, 2022

SELL
$72.28 - $90.54 $415,610 - $520,605
-5,750 Reduced 13.29%
37,500 $2.87 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $1.83 Million - $2.01 Million
-25,500 Reduced 37.09%
43,250 $3.25 Million
Q2 2021

Aug 11, 2021

BUY
$70.31 - $77.77 $3.01 Million - $3.32 Million
42,750 Added 164.42%
68,750 $5.35 Million
Q1 2021

May 11, 2021

BUY
$68.86 - $81.11 $946,825 - $1.12 Million
13,750 Added 112.24%
26,000 $2 Million
Q4 2020

Feb 10, 2021

BUY
$71.77 - $79.65 $879,182 - $975,712
12,250 New
12,250 $1 Million
Q1 2020

May 12, 2020

SELL
$63.36 - $87.82 $221,760 - $307,370
-3,500 Closed
0 $0
Q3 2019

Oct 31, 2019

SELL
$76.08 - $82.93 $38,040 - $41,465
-500 Reduced 12.5%
3,500 $295,000
Q2 2019

Aug 05, 2019

SELL
$69.84 - $81.59 $62,157 - $72,615
-890 Reduced 18.2%
4,000 $335,000
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $94,628 - $107,929
-1,360 Reduced 21.76%
4,890 $407,000
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $97,859 - $113,564
-1,500 Reduced 19.35%
6,250 $478,000
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $548,055 - $644,480
-9,500 Reduced 55.07%
7,750 $550,000
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $12,707 - $14,930
-250 Reduced 1.43%
17,250 $1.05 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $891,800 - $1.04 Million
17,500 New
17,500 $953,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $320B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Game Creek Capital, LP Portfolio

Follow Game Creek Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Game Creek Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Game Creek Capital, LP with notifications on news.